Inventor · disambiguated record
Akio Sugihara
Also filed as: SUGIHARA AKIO
8 granted patents·3 pending applications·33 citations·filing 2002–2017
81Inventor score
Files withASTELLAS PHARMA INC4FUJI CORP3OSAKA MUNICIPAL GOVERNMENT1YAMANOUCHI PHARMA CO LTD1YASUJI TAKEHIKO1
Top patents by PatentIndex Score
11 records- 0184US7442387B2Pharmaceutical composition for controlled release of active substances and manufacturing method thereofASTELLAS PHARMA INC·Filed 2003·Granted Oct 28, 2008·21 cites·31 claims
- 0277US8039482B2Composition of solifenacin or salt thereof for use in solid formulationASTELLAS PHARMA INC·Filed 2005·Granted Oct 18, 2011·4 cites·3 claims
- 0369US9198904B2Pharmaceutical composition for oral administrationYASUJI TAKEHIKO·Filed 2010·Granted Dec 1, 2015·2 cites·16 claims
- 0462US7220873B2Conjugated fatty acid containing monoglycerides and process for producing themOSAKA MUNICIPAL GOVERNMENT·Filed 2002·Granted May 22, 2007·4 cites·16 claims
- 0560US7794748B2Stable oral solid drug compositionYAMANOUCHI PHARMA CO LTD·Filed 2004·Granted Sep 14, 2010·2 cites·27 claims
- 0657US2009035372A1method for manufacturing a pharmaceutical composition for controlled release of an active substanceASTELLAS PHARMA INC·Filed 2008·Application pending·0 cites
- 0747US11089721B2Component supply systemFUJI CORP·Filed 2016·Granted Aug 10, 2021·0 cites·7 claims
- 0841US11632885B2Component supply deviceFUJI CORP·Filed 2017·Granted Apr 18, 2023·0 cites·7 claims
- 0941US11129316B2Component supply deviceFUJI CORP·Filed 2016·Granted Sep 21, 2021·0 cites·7 claims
- 1041US2011065746A1Composition of solifenacin or salt thereof for use in solid formulationASTELLAS PHARMA INC·Filed 2010·Application pending·0 cites
- 1131US2004115758A1Method of purifying crude xanthophyllsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Akio Sugihara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →